South & Central America Mid-Size Pharmaceutical Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)      

No. of Pages: 121    |    Report Code: BMIRE00026158    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Mid-Size Pharmaceutical Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Mid-Size Pharmaceutical Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Investment towards Improvement of Pharmaceutical Manufacturing Capabilities to boost the mid-size pharmaceutical market
5.2 Market Opportunities
  • 5.2.1 Active participation of market players in product innovation and developments fuel the growth of the mid-size pharmaceutical market
5.3 Future Trends
  • 5.3.1 Adoption of Tech Transfer and Outsourcing Trends providing a significant growth opportunity for the mid-size pharmaceutical market
5.4 Impact of Drivers and Restraints

6. South & Central America Mid-Size Pharmaceutical Market Regional Analysis

6.1 South & Central America Mid-Size Pharmaceutical Market Overview
6.2 South & Central America Mid-Size Pharmaceutical Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Mid-Size Pharmaceutical Market Forecast Analysis

7. South & Central America Mid-Size Pharmaceutical Market Analysis – by Type

7.1 Prescription
  • 7.1.1 Overview
  • 7.1.2 Prescription: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Over-the-Counter
  • 7.2.1 Overview
  • 7.2.2 Over-the-Counter: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Mid-Size Pharmaceutical Market Analysis – by Drug Development Type

8.1 In-House
  • 8.1.1 Overview
  • 8.1.2 In-House: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Outsource
  • 8.2.1 Overview
  • 8.2.2 Outsource: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Mid-Size Pharmaceutical Market Analysis – by Formulation

9.1 Tablets and Capsules
  • 9.1.1 Overview
  • 9.1.2 Outsource: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Injectables
  • 9.2.1 Overview
  • 9.2.2 Outsource: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Sprays
  • 9.3.1 Overview
  • 9.3.2 Outsource: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Other Formulations
  • 9.4.1 Overview
  • 9.4.2 Outsource: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Mid-Size Pharmaceutical Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Mid-Size Pharmaceutical Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.1.2 Brazil: South & Central America Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.1.3 Brazil: South & Central America Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.2 Argentina: South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.2.2 Argentina: South & Central America Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.2.3 Argentina: South & Central America Mid-Size Pharmaceutical Market Breakdown, by Formulation
  • 10.1.1.3 Rest of South and Central America : South & Central America Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Mid-Size Pharmaceutical Market Breakdown, by Type
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Mid-Size Pharmaceutical Market Breakdown, by Formulation

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Mid-Size Pharmaceutical Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Alexion Pharmaceuticals, Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bausch Health Companies Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Daiichi Sankyo Company Limited
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Endo Pharmaceuticals Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Mallinckrodt
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Sun Pharmaceutical Industries Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South & Central America Mid-Size Pharmaceutical Market

  1. Alexion Pharmaceuticals, Inc.
  2. Bausch Health Companies Inc.
  3. Daiichi Sankyo Company Limited
  4. Endo Pharmaceuticals Inc.
  5. Mallinckrodt
  6. Sun Pharmaceutical Industries Ltd
south-and-central-america-mid-size-pharmaceutical-market